Shay Capital LLC 13D/13G Filings for PharmaCyte Biotech, Inc. (PMCB)

Shay Capital LLC 13D and 13G filings for PharmaCyte Biotech, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2023-02-14
4:30 pm
Sale		2022-12-3113GPharmaCyte Biotech, Inc.
PMCB		Shay Capital LLC0
0.000%		-1,037,882decrease
(Position Closed)		Filing
2022-10-20
10:38 am
Purchase		2022-10-1013GPharmaCyte Biotech, Inc.
PMCB		Shay Capital LLC1,037,882
5.000%		1,037,882increase
(New Position)		Filing